I saw the news recently that the Food and Drug Administration is proposing to remove a popular ingredient in over-the-counter ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

FDA approves esketamine nasal spray as a standalone treatment for adults with treatment-resistant depression, offering rapid ...

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

MUNICH, Germany I January 30, 2025 I Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

It is a container that holds saline solution which rises the nasal passages. There are various kinds of nasal irrigation ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.